CDMO vs ESPR

Comparison between Avid Bioservices Inc (CDMO, Company) and Esperion Therapeutics Inc (ESPR, Company).

5-Year PerformanceCDMO has outperformed ESPR, delivering a return of +13.9% compared to -29.6%

CDMO vs ESPR - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	CDMO(COMPANY)	ESPR(COMPANY)
Market Cap	$797M	$799M
Max Drawdown	86.42%	99.37%
Sharpe Ratio	1.31	1.41
Industry	N/A	Drug Manufacturers - Specialty & Generic
P/E Ratio	-5.20	-6.03
Forward P/E	N/A	4.64
PEG Ratio	N/A	-0.75
5Y EPS CAGR	N/A	-31.57%
Debt to Equity	358.17%	0.00%
Free Cash Flow Yield	-1.21%	-2.30%
P/S Ratio	5.30	N/A
P/B Ratio	17.79	N/A

Market Cap

CDMO

$797M

Winner

ESPR

$799M

Max Drawdown

Winner

CDMO

86.42%

ESPR

99.37%

Sharpe Ratio

CDMO

1.31

Winner

ESPR

1.41

Industry

CDMO

N/A

ESPR

Drug Manufacturers - Specialty & Generic

P/E Ratio

CDMO

-5.20

Winner

ESPR

-6.03

Forward P/E

CDMO

N/A

ESPR

4.64

PEG Ratio

CDMO

N/A

ESPR

-0.75

5Y EPS CAGR

CDMO

N/A

ESPR

-31.57%

Debt to Equity

CDMO

358.17%

Winner

ESPR

0.00%

Free Cash Flow Yield

Winner

CDMO

-1.21%

ESPR

-2.30%

P/S Ratio

CDMO

5.30

ESPR

N/A

P/B Ratio

CDMO

17.79

ESPR

N/A

CDMO vs ESPR - Historical Returns

Returns include dividend reinvestment.

Period	CDMO	ESPR
1 month	+1.05%	+0.95%
3 months	+18.50%	+43.24%
6 months	+18.84%	-3.64%
1 year	+99.20%	+169.49%
5 years(CAGR)	+13.88%	-29.55%
10 years(CAGR)	N/A	-11.39%
Max(CAGR)	+20.82%	-10.98%

Winner

CDMO

+1.05%

ESPR

+0.95%

CDMO

+18.50%

Winner

ESPR

+43.24%

Winner

CDMO

+18.84%

ESPR

-3.64%

CDMO

+99.20%

Winner

ESPR

+169.49%

5Y(CAGR)

Winner

CDMO

+13.88%

ESPR

-29.55%

10Y(CAGR)

CDMO

N/A

ESPR

-11.39%

Max(CAGR)

Winner

CDMO

+20.82%

ESPR

-10.98%

CDMO vs ESPR - Annual Returns (2013 - 2026)

Returns include dividend reinvestment.

Year	CDMO	ESPR
2026	N/A	-14.29%
2025	+1.38%	+68.18%
2024	+94.18%	-24.66%
2023	-51.78%	-48.80%
2022	-50.34%	+20.04%
2021	+146.04%	-81.96%
2020	+56.16%	-57.61%
2019	+79.63%	+30.45%
2018	+25.18%	-30.83%
2017	N/A	+411.18%
2016	N/A	-42.17%
2015	N/A	-46.01%
2014	N/A	+191.35%
2013	N/A	-5.24%

CDMO vs ESPR Drawdown Comparison

The maximum drawdown for CDMO was -86.42%, occurring on Dec 8, 2023. This drawdown has not yet recovered.

The maximum drawdown for ESPR was -99.37%, occurring on May 14, 2025. This drawdown has not yet recovered.

The current CDMO drawdown is -63.46%. The current ESPR drawdown is -97.24%.

Rank	CDMO	ESPR
#1	-86.42% Nov 5, 2021 - Dec 8, 2023	-99.37% May 19, 2015 - May 14, 2025
#2	-61.40% Dec 26, 2019 - Aug 13, 2020	-41.24% Oct 2, 2013 - Sep 26, 2014
#3	-53.14% Aug 31, 2018 - Dec 12, 2019	-28.66% Oct 8, 2014 - Oct 31, 2014
#4	-44.83% Jan 9, 2018 - Apr 4, 2018	-22.60% Mar 23, 2015 - May 19, 2015
#5	-32.73% Aug 10, 2021 - Oct 26, 2021	-18.82% Aug 5, 2013 - Sep 26, 2013
#6	-26.46% Mar 1, 2021 - Apr 28, 2021	-13.95% Oct 31, 2014 - Nov 12, 2014
#7	-21.10% Aug 19, 2020 - Nov 12, 2020	-12.84% Jan 14, 2015 - Feb 3, 2015
#8	-20.51% Apr 26, 2018 - Jun 27, 2018	-12.54% Dec 9, 2014 - Dec 31, 2014
#9	-12.36% Jul 20, 2018 - Aug 24, 2018	-12.35% Feb 18, 2015 - Mar 12, 2015
#10	-11.68% Apr 28, 2021 - Jun 3, 2021	-10.06% Nov 18, 2014 - Dec 4, 2014
#11	-7.94% Apr 4, 2018 - Apr 24, 2018	-6.74% Jan 12, 2015 - Jan 14, 2015
#12	-6.84% Dec 4, 2020 - Dec 18, 2020	-6.30% Jan 8, 2015 - Jan 12, 2015
#13	-6.70% Feb 8, 2021 - Feb 24, 2021	-3.45% Jun 26, 2013 - Jul 2, 2013
#14	-6.29% Jul 10, 2018 - Jul 17, 2018	-3.06% Jul 16, 2013 - Jul 29, 2013
#15	-6.27% Jul 8, 2021 - Aug 9, 2021	-2.87% Sep 26, 2014 - Sep 30, 2014

Correlation

Correlation between CDMO and ESPR is -0.56 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.

-0.56

-101